Request To Download Free Sample of This Strategic Report @ The Vietnam Acute Kidney Injury (AKI) Treatment Market report provides a comprehensive analysis of the current landscape and future trends ...
No previous study has investigated whether glucarpidase improves important clinical outcomes in patients with methotrexate-associated acute kidney injury (AKI).
New research connects mild acute kidney injury (AKI) with increased risks of dementia and cognitive impairment in older adults. Explore the implications for long-term cognitive health and care ...
Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXtm (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal ...
KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.